<DOC>
	<DOCNO>NCT00092768</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness investigational drug approve drug treatment osteoarthritis knee hip .</brief_summary>
	<brief_title>A Study MK0663 Approved Drug Treatment Osteoarthritis ( 0663-076 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 26 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Osteoarthritis knee hip require treatment medication obtain pain relief Any known allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>